These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 4902882)

  • 1. European legislation on flavourings.
    Food Cosmet Toxicol; 1969 Sep; 7(5):531-3. PubMed ID: 4902882
    [No Abstract]   [Full Text] [Related]  

  • 2. The safety of flavoring substances.
    Hall RL; Oser BL
    Residue Rev; 1968; 24():1-17. PubMed ID: 4880908
    [No Abstract]   [Full Text] [Related]  

  • 3. [About flavouring substances and flavouring preparations regulation in the field of manufacturing of flavourings and foodstuffs].
    Bagriantseva OV; Shatrov GN
    Vopr Pitan; 2013; 82(1):23-32. PubMed ID: 23808275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Criteria employed by the expert panel of FEMA for the GRAS evaluation of flavouring substances.
    Oser BL; Hall RL
    Food Cosmet Toxicol; 1977 Oct; 15(5):457-66. PubMed ID: 598799
    [No Abstract]   [Full Text] [Related]  

  • 5. Safety evaluation of food flavorings.
    Schrankel KR
    Toxicology; 2004 May; 198(1-3):203-11. PubMed ID: 15138043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of dietary intake of flavouring substances within the procedure for their safety evaluation: advantages and limitations of estimates obtained by means of a per capita method.
    Arcella D; Leclercq C
    Food Chem Toxicol; 2005 Jan; 43(1):105-16. PubMed ID: 15582202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pronatalist policies in Eastern Europe and France.
    Girard A
    Draper Fund Rep; 1983 Aug; (12):6-7. PubMed ID: 12338982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Examination of Mexican vanilla extracts for coumarin adulteration: part I.
    Sullivan G
    Vet Hum Toxicol; 1981 Apr; 23(2):89-91. PubMed ID: 7292955
    [No Abstract]   [Full Text] [Related]  

  • 9. Issues with regulatory pharmacovigilance in East European countries: the industry perspective.
    Hanzl-Dujmović I; Sulić-Milisić Z; Staresinić-Sernhorst I
    Toxicol Lett; 2007 Feb; 168(3):228-35. PubMed ID: 17161561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Criteria in defining the priority of synthetic flavoring agents].
    Tosato ML; Marchini S
    Boll Chim Farm; 1987 Mar; 126(3):136-43. PubMed ID: 3689579
    [No Abstract]   [Full Text] [Related]  

  • 11. GRAS evaluation of flavoring substances by the Expert Panel of FEMA.
    Woods LA; Doull J
    Regul Toxicol Pharmacol; 1991 Aug; 14(1):48-58. PubMed ID: 1947245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Examination of Mexican vanilla extracts for coumarin adulteration: Part II.
    Sullivan G
    Vet Hum Toxicol; 1981 Jun; 23(3):161-3. PubMed ID: 7245600
    [No Abstract]   [Full Text] [Related]  

  • 13. [European legislation on biological similarity recommendations of the European Agency on Medications concerning drug quality].
    Prugnaud JL
    Nephrol Ther; 2009 Feb; 5 Spec No1():3-5. PubMed ID: 19233075
    [No Abstract]   [Full Text] [Related]  

  • 14. [The legislation on abortion in Eastern Europe and the USSR].
    Hecht J
    Politiq Popul; 1987 Jun; 3(1):89-105. PubMed ID: 12281172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [European legislation on the development of biological similarity: recommendations on the European Agency on Medications with regard to efficacy and safety].
    London G
    Nephrol Ther; 2009 Feb; 5 Spec No1():6-9. PubMed ID: 19233076
    [No Abstract]   [Full Text] [Related]  

  • 16. [European drug policy].
    Sauer F
    Bull Mem Acad R Med Belg; 1993; 148(5-6):207-12; discussion 212-6. PubMed ID: 8142930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specifications for the identity and purity of food additives and their toxicological evaluation: some flavouring substances and non-nutritive sweetening agents.
    FAO Nutr Meet Rep Ser; 1968; 44():1-18. PubMed ID: 5760871
    [No Abstract]   [Full Text] [Related]  

  • 18. Orphan drug development across Europe: bottlenecks and opportunities.
    Heemstra HE; de Vrueh RL; van Weely S; Büller HA; Leufkens HG
    Drug Discov Today; 2008 Aug; 13(15-16):670-6. PubMed ID: 18583178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategic orientation of public health in transition: an overview of South Eastern Europe.
    Bjegovic V; Vukovic D; Terzic Z; Milicevic MS; Laaser UT
    J Public Health Policy; 2007; 28(1):94-101. PubMed ID: 17363940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Population policies in the European socialist countries].
    Szabady E
    Stat Szle; 1977; 55(11):1,089-100. PubMed ID: 12263844
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.